Abstract Hyperglycaemia and oxidative stress are known to acutely cause endothelial dysfunction in vitro, but in the initial stages of diabetes, endothelium-dependent relaxation is preserved. The aim of this study was to investigate how endothelium-dependent relaxation is maintained in the early stages of type 1 diabetes. Diabetes was induced in SpragueDawley rats with a single injection of streptozotocin (48 mg/ kg, i.v.), and after 6 weeks, endothelium-dependent and endothelium-independent relaxations were examined in the thoracic aorta in vitro. Lucigenin-enhanced chemiluminescence was used to measure superoxide generation from the aorta. Diabetes increased superoxide generation by the aorta (2,180±363 vs 986± 163 AU/mg dry tissue weight). Acetylcholine (ACh)-induced relaxation was similar in aortae from control (pEC 50 7.36±0.09, R max 95±3 %) and diabetic rats (pEC 50 7.33±0.10, R max 88± 5 %). The ACh-induced relaxation was abolished by the combined presence of the nitric oxide synthase inhibitor N-nitro-L-arginine (L-NNA, 100 μM) and an inhibitor of soluble guanylate cyclase, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 μM) in control rats, but under the same conditions, the diabetic aortic rings showed significant relaxation to ACh (pEC 50 6.75±0.15, R max 25±4 %, p<0.05). In diabetic aortae, the addition of haemoglobin, which inactivates nitric oxide, to L-NNA + ODQ abolished the response to ACh. The addition of the potassium channel blockers, apamin and TRAM-34, to L-NNA + ODQ also abolished the relaxation response to ACh. Diabetes significantly elevated plasma total nitrite/nitrate and increased expression of endothelial nitric oxide synthase (eNOS) and calmodulin in aortae. These data indicate that after 6 weeks of diabetes, despite increased oxidant stress, endothelium-dependent relaxation is maintained due to the increased eNOS expression resulting in increased NO synthesis. In diabetic arteries, NO acts both through and independently of cGMP pathways to cause relaxation.
Introduction
Cardiovascular complications are the major cause of morbidity and mortality in diabetic patients (Lopes-Virella et al. 2008 ).
The pathogenic role of glucose in cardiovascular disease is increasingly apparent, as confirmed by studies carried out both on diabetic and nondiabetic patients (Bartnik et al. 2007 ). Acute hyperglycaemia (3-6 h) induces endothelial dysfunction of the aorta as well as of the renal circulation of nondiabetic rabbits (Gomes et al. 2004) , and numerous studies report that longterm hyperglycaemia leads to endothelial dysfunction in various animal models of diabetes (Pieper et al. 1998; Pieper 1999; Csanyi et al. 2007 ) and in humans (Johnstone et al. 1993) . Hyperglycaemia both acute (Goel et al. 2007 ) and chronic (Karasu 2000) is known to induce oxidative stress, and it has been proposed that oxidative stress leads to endothelial dysfunction (Ammar et al. 2000; Hink et al. 2001; Jay et al. 2006) . It is surprising then to note that there are several reports that endothelial function is normal after a short duration (2-4 weeks) of diabetes despite the presence of hyperglycaemia (Orie et al. 1993; Pieper 1999; Shen et al. 2003) . Pieper (1999) reported a triphasic effect of diabetes on endothelial function. Initially, endothelium-dependent relaxation was increased after 1 week of diabetes followed by a normal response after 2 weeks and impaired response after 8 weeks of diabetes. While the mechanism of endothelial dysfunction has been extensively studied in long-term diabetes, it still remains to be elucidated how endotheliumdependent relaxation is maintained in the early stages of type 1 diabetes.
The endothelium produces vasodilators such as nitric oxide, prostacyclin and a still unidentified endotheliumderived hyperpolarising factor (EDHF) (Bryan et al. 2005 ). Nitric oxide is considered to be the main endotheliumderived relaxing factor in larger arteries (Clark and Fuchs 1997) . The major source of nitric oxide in the endothelium is endothelial nitric oxide synthase (eNOS), but a small amount of nitric oxide may also be released from preformed endothelial nitrosothiol stores (Alencar et al. 2003; Lima et al. 2010) .
There are several possible mechanisms that may contribute to the maintenance of endothelial function in short-term diabetes, e.g. increased production of nitric oxide (Stadler et al. 2003) , increased expression of eNOS (Hink et al. 2001) or a compensatory upregulation of the release of other vasodilators (Shi et al. 2006; Malakul et al. 2008; Nacci et al. 2009) . Several studies have shown increased nitric oxide production in the early stages of diabetes. Stadler et al. (2003) reported increased production of nitric oxide in aortae from diabetic rats for a limited time after induction of diabetes (up to 7 weeks). There are conflicting reports regarding expression of eNOS at various stages of diabetes. Hink et al. (2001) showed an increased expression of eNOS but decreased basal nitric oxide in aortae after 2 weeks of diabetes leading the authors to propose that eNOS became uncoupled and shifted towards superoxide rather than nitric oxide synthesis whereas Bojunga et al. (2004) reported a decreased expression of eNOS in diabetic aorta but increased production of nitric oxide. On the other hand, increased expression of inducible NOS has also been demonstrated in diabetic rat aorta and heart (Bojunga et al. 2004; Jesmin et al. 2006) . Overall, it has been demonstrated that whereas diabetes induces endothelial dysfunction by decreased synthesis or increased breakdown of nitric oxide (Beckman and Crow 1993; Jay et al. 2006) in the longer term, it is yet not clear what changes take place in early diabetes to maintain endothelial function despite hyperglycaemia and oxidative stress.
As there has been limited investigation of the mechanism of relaxation in early diabetes (Shen et al. 2003; Abboud et al. 2009 ), the purpose of this study was to gain better understanding of the mechanism of endothelium-dependent relaxation in the early stages of type 1 diabetes before acetylcholine-induced relaxation is impaired with a focus on the determination of the role of various endotheliumderived vasodilators in maintaining endothelial function in the presence of increased oxidative stress.
Methods

Animals
Male Sprague-Dawley rats (200-230 g, 8 weeks; Animal Resource Centre, Perth, WA) were housed two to three per cage, fed with standard rat chow and had free access to food and water. All the experiments were performed according to the guidelines of the National Health and Medical Research Council of Australia and approved by the Animal Ethics Committees of the University of Melbourne and RMIT University.
Induction of diabetes
Diabetes was induced in rats by a single injection of streptozotocin (48 mg/kg) dissolved in 0.1 M citrate buffer (pH 4.5) into the tail vein after an overnight fast. Control rats received an injection of citrate buffer. Blood glucose was measured at the time of experiment for all groups using an Accu-Chek Advantage II monitor (Roche, Mannheim, Germany). The rats showing blood glucose of >20 mmol/ L were considered to be diabetic.
Preparation of aortic rings
The rats were killed 6 weeks after streptozotocin or vehicle injection by exposure to a mixture of halothane and oxygen for 5 min. The chest was opened and the thoracic aorta was isolated. After removing superficial fat and connective tissue, the thoracic aorta was cut into 2-3-mm-long rings and mounted in organ baths in Krebs bicarbonate solution (118 mM NaCl, 4.7 mM KCl, 1.18 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 25 mM NaHCO 3 , 11.1 mM D-glucose and 1.6 mM CaCl 2 ), bubbled with 5 % CO 2 in O 2 at 37°C to assess vascular function. Blood plasma was collected for NOx assay, and from some of the rats, the thoracic aorta was isolated and immediately frozen for Western blotting.
Functional experiments
The aortic rings, mounted in organ baths at a resting tension of 1 g, were equilibrated for 60-90 min with the bath medium changed every 15 min. The tissues were maximally contracted by exposure to physiological saline solution containing a high potassium concentration of 123 mM. Endothelial integrity was determined by measuring the relaxation caused by exposure to acetylcholine (10 −5 M) in phenylephrine-precontracted rings, and the endothelium was considered to be intact if the preparation relaxed by greater than 80 %. Cumulative concentration response curves to acetylcholine and sodium nitroprusside were determined using rings submaximally contracted with phenylephrine (10 −8 to 10 −7 M). Responses to acetylcholine and sodium nitroprusside were also tested in the presence or Lucigenin-enhanced chemiluminescence assay Lucigenin-enhanced chemiluminescence was used to measure superoxide release from aortic rings that were not used in the functional experiments, using a previously described procedure (Chan et al. 2003) . At the conclusion of the assay, tissues were dried for 48 h at 65°C to allow superoxide production to be normalised to dry tissue weight. The results were expressed as superoxide counts per milligram tissue.
Western blot analysis
Western blots were performed as described previously ) with the following modifications:
The aortic tissues were homogenized, and the total protein concentration of the samples was quantified using a Bradford assay. Equal amounts of protein homogenate were subjected to SDS-PAGE, and Western blot analysis with mouse antibodies against eNOS, inducible-NOS, caveolin-1 (Transduction Laboratories), calmodulin (Millipore), NADPH oxidase (NOX)-2 and heme oxygenase-1 (Abcam). To normalise for the amount of protein loaded on the gels, membranes were reprobed with a loading control antibody (β-tubulin, Abcam). All proteins were detected by enhanced chemiluminescence (Amersham) after incubation with antimouse secondary antibody. All protein bands were quantified by densitometry (Bio-Rad ChemiDoc) and expressed as a ratio of the loading control.
Nitrite estimation
The level of nitric oxide metabolites (NOx, i.e. nitrite + nitrate) was measured in plasma using a colorimetric assay kit (Roche Diagnostics). Plasma samples were stored at −80°C until assayed. The concentration of NOx was measured in samples of plasma after converting all nitrates to nitrite with nitrate reductase. Total nitrite levels were measured in duplicate by absorbance at 560 nm using the Griess reaction. The calibration curve was prepared using sodium nitrite as a standard.
Drugs
Acetylcholine perchlorate (BDH Chemicals), apamin (Sigma), L-cysteine (Sigma), p-hydroxymercuribenzoic acid (Sigma) and phenylephrine hydrochloride (Sigma) were all dissolved in distilled water. Haemoglobin (Sigma) and sodium nitroprusside (Sigma) were dissolved in Krebs solution. Indomethacin (Sigma) was dissolved in 0.1 M sodium carbonate, and L-NNA (Sigma) was dissolved in 0.1 M sodium bicarbonate. Ethacrynic acid (Sigma), ODQ (Cayman), carboxy-PTIO (Cayman) and TRAM-34 (Sigma) were dissolved in dimethyl sulfoxide. The final concentrations of DMSO in the bath were 0.0001-0.01 % while performing the functional experiments, which has been shown to have no effect on vasorelaxation in these concentrations.
Analysis and statistics
Concentration-response data were fitted to a sigmoidal plot using GraphPad Prism version 5.0, which estimated the pEC 50 . Statistical analysis was carried out using Student's unpaired t test, or multiple comparisons were performed using analysis of variance (ANOVA) followed by a Bonferroni post test. p<0.05 was considered statistically significant. All values are presented as mean ± SEM. Each n represents the number of animals per group.
Results
Blood glucose and body weight
The control and diabetic animals had a similar initial body weight, but diabetic animals had a significantly lower body weight at the end of 6 weeks compared to control animals ( Table 1 ). All of the diabetic animals exhibited hyperglycaemia at the time of experiment.
Vascular superoxide
Superoxide counts measured from segments of thoracic aorta were significantly higher in diabetic animals compared to control animals using the lucigenin-enhanced chemiluminescence assay. Diphenyliodonium, a nonselective inhibitor of NADPH oxidase, reduced the amount of superoxide generation in both groups (Table 1) . L-NNA, a NOS inhibitor, reduced superoxide counts in diabetic aorta but not in control aorta (Table 1) .
Plasma nitrite concentrations
The diabetic animals showed significantly higher plasma NOx concentration compared to control animals (Table 1) .
Endothelium-dependent and endothelium-independent relaxations
Six weeks after streptozotocin injection, endotheliumdependent and endothelium-independent relaxations to acetylcholine (10 −10 to 10 −5 M) and sodium nitroprusside (10
to 10 −5 M), respectively, were similar in aortae from control and diabetic animals ( Fig. 1 ).
Effect of L-NNA, ODQ and indomethacin on relaxation
The presence of L-NNA or ODQ completely abolished acetylcholine-induced relaxation in control aortae (Fig. 2a ).
In the aortic rings from diabetic animals, the relaxation was partially inhibited, but not abolished, by L-NNA or ODQ (Fig. 2b ). Pretreatment with indomethacin had no effect on relaxation to either acetylcholine (ACh) or SNP in normal or diabetic animals (Fig. 2) . The diabetic animals showed a higher sensitivity to the nitric oxide donor sodium nitroprusside in the presence of L-NNA and ODQ compared to control animals ( Table 2 ).
Effect of nitric oxide scavengers on relaxation
The presence of the nitric oxide scavenger haemoglobin in addition to L-NNA + ODQ abolished the relaxation response to acetylcholine in diabetic aortae (Fig. 3a) . The presence of haemoglobin significantly decreased the pEC 50 to sodium nitroprusside in control as well as diabetic aortae. Carboxy-PTIO and L-cysteine also significantly decreased the pEC 50 and R max to acetylcholine in diabetic aorta when used in combination with L-NNA (Fig. 3b) . The pEC 50 and R max values for acetylcholine and sodium Table 2 nitroprusside in the presence of these inhibitors are shown in Tables 2, 3 and 4.
Effect on relaxation of agents depleting nitrosothiol stores
The role of preformed nitrosothiol stores in relaxation response to acetylcholine in diabetic aorta was examined using nitrosothiol-depleting agent ethacrynic acid and p-hydroxymercuribenzoic acid (PHMBA). The aortic rings were incubated for 20 min with L-NNA with or without ethacrynic acid or PHMBA. After the first exposure of acetylcholine, the rings incubated with ethacrynic acid or PHMBA showed significantly less relaxation compared to L-NNA-incubated rings (Fig. 4) . After the second exposure to acetylcholine, the ethacrynic acid-and PHMBA-incubated rings showed contraction indicating a complete depletion of nitrosothiol stores.
Effect of potassium channel blockers on relaxation
The presence of apamin plus TRAM-34 had no effect on vasorelaxation to acetylcholine or to sodium nitroprusside in control aortae (Fig. 2c) , whereas in diabetic animals, they significantly decreased the maximum relaxation to acetylcholine (Fig. 2d ) but had no effect on sodium nitroprusside responses (Table 3) . In diabetic animals, the relaxation to acetylcholine observed in the presence of ODQ plus L-NNA was abolished by the addition of apamin and TRAM-34 (Fig. 2d) and the maximum response to sodium nitroprusside was significantly decreased compared to control aortae (Table 3) .
Protein expression by Western blot analysis
The expression of eNOS, calmodulin and NADPH oxidase-2 was found to be significantly increased in aortae from the diabetic group compared to control (Fig. 5) . The eNOS dimer-monomer ratio was significantly decreased in diabetic aorta. The expression of caveolin and heme oxygenase-1 was not altered by diabetes. Inducible NOS expression was not detected in either of the groups (data not shown).
Discussion
Our study showed that, despite an increase in oxidative stress, endothelium-dependent and endothelium-independent relaxations of the rat aorta were unaltered in the early stages of diabetes, but the mechanism of endothelium-dependent relaxation had been changed. We found that endotheliumdependent relaxation of diabetic aortae was resistant to inhibition by a NOS inhibitor and/or inhibition of sGC and that the remaining component of relaxation was sensitive to SK Ca Tables 2 and 3 and IK Ca channel blockers as well as nitric oxide scavengers. In diabetic arteries, the nitrosothiol-depleting agents also abolished the relaxation response to acetylcholine that persisted in the presence of L-NNA. Western blot analysis showed increased expression of eNOS and calmodulin in diabetic aortae, which may explain the increase in nitric oxide synthesis, indicated by the elevation in plasma nitrite levels. These results suggest that despite increased oxidative stress, endothelial function was maintained in early diabetes due to a compensatory increased activity of nitric oxide which acted primarily through activating soluble guanylate cyclase and partly through the opening of potassium channels. In diabetes, nitrosothiol stores acted as the additional source of nitric oxide in addition to eNOS.
Hyperglycaemia increases superoxide production by several mechanisms, including autooxidation of glucose, activation of polyol pathways and generation of advanced glycation end products (Jay et al. 2006) . Several enzymes are involved in the production of ROS at a vascular level such as cyclooxygenase, NADPH oxidase and xanthine oxidase (Ellis and Triggle 2003) . In vascular disease, uncoupling of NOS also accounts for the increased ROS production. In this study, diabetic animals showed an increase in oxidative stress measured by production of superoxide counts using lucigenin-enhanced chemiluminescence. We also found increased expression of NADPH oxidase-2 in diabetic rat aorta compared to control animals (Fig. 5) .
Diphenyliodonium, a nonselective inhibitor of NADPH oxidase enzyme, blocked the production of superoxide in lucigenin assay (Table 1) suggesting that NADPH oxidase is the major source of superoxide. The dimer-monomer ratio of eNOS was decreased in diabetic animals (Fig. 5) suggesting that eNOS was in an uncoupled form and therefore may also contribute to superoxide production. L-NNA decreased superoxide generation in lucigenin assay in diabetic aorta suggesting that eNOS also contributed partly to superoxide generation in diabetic aorta. These results are consistent with other studies which have shown increased oxidative stress (Bitar et al. 2005; Ding et al. 2007 ) as well as increased activity/expression of NADPH oxidase, p22 phox and p67phox subunits in diabetes (Wendt et al. 2005; Guo et al. 2007 ). It has also been suggested that eNOS can exist simultaneously both as dimer and monomer in endothelial cells and can contribute to NO as well as superoxide production (Sullivan and Pollock 2006) . Hyperglycaemia, both acute and chronic, has been widely reported to cause endothelial dysfunction. Rat aortic rings showed a diminished response to endothelium-dependent vasodilator when incubated with high glucose for 2-6 h (Gomes et al. 2004; Goel et al. 2007; Fang et al. 2009 ). By contrast, diabetic animals have shown variable endotheliumdependent relaxation responses depending upon the duration of diabetes (Pieper 1999) . In the early stages of diabetes (1-6 weeks of induction), it has been reported that endotheliumdependent relaxation is unaltered (Orie et al. 1993; Garcia et al. 1999) or increased in rats (Altan et al. 1989) or mice (Shen et al. 2003) . By contrast, there are numerous studies which have reported decreased relaxation responses in various animal models of long-term diabetes (8 weeks or more) (Oyama et al. 1986; Garcia-Pascual et al. 1995; Bitar et al. 2005; Alper et al. 2006) . Whilst the mechanism of endothelial dysfunction has been widely explored in long-term diabetes, it is yet to be established why endothelium-dependent relaxation is either unchanged or increased in early diabetes. In aortae, the endothelium-dependent relaxation is normally mediated entirely by nitric oxide through the activation of sGC (Clark and Fuchs 1997) . This was confirmed by the complete blockade of acetylcholine-induced relaxation by the NOS inhibitor, L-NNA, or the sGC inhibitor ODQ in control animals. By contrast, aortae from the diabetic animals showed significant relaxation in the presence of L-NNA, ODQ or the combination of both. We postulated that this might be due to increased nitric oxide activity or that there might be a compensatory upregulation of another nonnitric-oxide pathway of relaxation. We investigated the possibility of increased nitric oxide activity by using nitric oxide scavengers, in combination with L-NNA and ODQ. The L-NNA-and ODQ-resistant relaxation to acetylcholine was found to be sensitive to haemoglobin (Fig. 3a) and was also significantly decreased by L-cysteine, a scavenger of All the experiments were performed in the presence of indomethacin. The combination of apamin + TRAM-34 had no effect on relaxation in any of the group. ODQ + L-NNA + apamin + TRAM-34 treatment completely abolished relaxation in both groups. Responses to ACh in the diabetic group showed a resistance to inhibition by L-NNA + ODQ but were abolished by the additional presence of Hb. The data are expressed as mean ± SEM n number of experiments, ND not determined *p<0.05, significantly different compared to vehicle in the same treatment group (one-way ANOVA, Bonferroni post test); **p<0.05, significantly different compared to the same treatment group from the control animals (Student's unpaired t test) (Ng et al. 2007 ).
Nitrosothiol-derived compounds have been suggested to be potent vasodilators (Myers et al. 1990; Bates et al. 1991) which may cause relaxation mediated by both sGC and the opening of SK Ca and IK Ca channels (Batenburg et al. 2009 ), and recent reports suggest a physiological role for NO − in spreading vasodilation (Yuill et al. 2011) . It is also interesting to note that vasorelaxant responses to nitroxyl donors are maintained in the presence of oxidant stress (Bullen et al. 2011) supporting the possibility that NO − might contribute to relaxation in diabetes. Our results using nitrosothioldepleting agents (Fig. 4) also support a contribution of nitric oxide released from pre-formed nitrosothiol stores towards endothelium-dependent relaxation in early diabetes. This is consistent with the observations of Ng et al. (2007) who concluded that relaxation caused by ultraviolet light involved the release of pre-formed NO stores that was unaffected by type 2 diabetes. In our study, diabetic animals showed a significant increase in total plasma nitrite/nitrate levels (Table 1) consistent with earlier reports that demonstrated increased nitrite levels in short-term (4 weeks) diabetes (Bojunga et al. 2004) . Stadler et al. (2003) found increased nitric oxide levels in diabetic aorta starting from 2 up to 7 weeks after diabetes induction. We also observed increased expression of eNOS protein in diabetic aorta (Fig. 5 ), but inducible NOS was not detected. Several studies in diabetes had reported an upregulated, but dysfunctional, uncoupled Fig. 4 Effect of the nitrosothiol-depleting agents ethacrynic acid (50 μM) and p-hydroxymercuribenzoic acid (10 μM) on relaxation responses to three consecutive exposures to ACh (10 μM) in the presence of L-NNA (100 μM). All experiments were performed in the presence of indomethacin (10 μM). *p<0.05, significantly different compared to L-NNA-treated rings (one-way ANOVA, Bonferroni post test). n04 for each data set NOS leading to increased oxidative stress and endothelial dysfunction (Hink et al. 2001; Satoh et al. 2005 ), and we also found a lower expression for the eNOS dimer and higher expression for the eNOS monomer indicating uncoupling and the potential to generate superoxide rather than nitric oxide. The lucigenin assay results supported these findings (Table 1) . A further possibility is that in the presence of elevated oxidant stress, the consequent depletion of BH 4 could promote the synthesis of NO − rather than NO by eNOS as previously reported (Rusche et al. 1998; Adak et al. 2000) . We also investigated expression of two proteins that modulate eNOS activity (i.e. calmodulin and caveolin-1). The constitutively expressed eNOS is catalytically inactive when bound to caveolin-1; however, calmodulin displaces caveolin-1 in the presence of calcium and binds to eNOS and thereby activates eNOS to produce nitric oxide (Frank et al. 2007) . We found that the expression of calmodulin was significantly increased while expression of caveolin-1 remained unchanged in diabetes. Takahashi and Mendelsohn (2003) reported that calmodulin causes concentration-dependent increases in eNOS activity in vitro, and we, and others, have reported that an increase in calmodulin expression in vivo is associated with an increase in eNOS activity (Sobey et al. 2004; Woodman et al. 2004; Vera et al. 2007 ). This suggested that eNOS activity may be increased due to increased calmodulin binding despite a decreased dimer formation in diabetic aorta. Therefore, diabetic animals may produce more nitric oxide due to increased eNOS activity, to resist endothelial dysfunction caused by increased oxidative stress. There have been conflicting findings regarding eNOS regulation in diabetic animals with reports of both an increased (Stockklauser-Färber et al. 2000) or decreased (Komers et al. 2006 ) expression. Stockklauser-Färber et al. (2000 found that initially, cardiac NOS expression and activity increased to a maximum after 4-6 weeks of diabetes and then decreased afterwards. They suggested that high glucose could lead to induction of eNOS in the early stages of diabetes in response to increased ROS production as the increase in eNOS could be blocked by antioxidant treatment. In a recent study, Riad et al. (2008) found a marked decrease in eNOS expression in diabetic skeletal muscle after 8 weeks of streptozotocin injection and stimulation of eNOS production by eNOS transcription enhancer AVE3085 improved endothelial function and reduced oxidative stress and vascular inflammatory responses. Taken together, our results suggested a compensatory increase in basal nitric oxide levels to combat increased oxidative stress in diabetic aorta. The endothelial SK Ca and IK Ca channels have been reported to contribute to ACh-induced endothelial hyperpolarisation and NO-mediated relaxation in large arteries (Stankevicius et al. 2006) . It is also reported that opening of SK Ca and IK Ca channels decreases myogenic tone and increases ACh-induced relaxation in rat cremaster arterioles (Sheng et al. 2009 ) and restores attenuated EDHF-type relaxation in mesenteric small arteries from Zucker diabetic fatty rats (Brondum et al. 2010) . Also, recent studies have suggested that SK Ca and IK Ca channel opening is associated with the activation of NO synthase and NO production (Stankevicius et al. 2006; Sheng and Braun 2007; Brahler et al. 2009; Sheng et al. 2009; Dalsgaard et al. 2010) . The production of endothelium-dependent relaxing factors generally involves an increase in the intracellular Ca 2+ concentration [Ca 2+ ] i. An increase in endothelial [Ca 2+ ]i will open calcium-activated potassium channels of small (SK Ca ) and intermediate (IK Ca ) conductance, thereby hyperpolarising the endothelial cell. A recent study showed that the SK Ca and IK Ca channel opener NS309 induced calcium influx that contributed to the formation of NO (Stankevicius et al. 2011) . However, further studies are required to clarify how activation of these mechanisms is coupled to increased formation of NO in endothelial cells.
Conclusion
Previous studies have suggested that acute hyperglycaemia (Bartnik et al. 2007; Cameron and Cruickshank 2007) or long-term diabetes, i.e. 8 weeks or more (Hink et al. 2001; Peredo et al. 2006) , could lead to endothelial dysfunction due to increased oxidative stress and decreased nitric oxide bioavailability. We suggest that, in diabetes, an initial increased synthesis of nitric oxide by increased activity of eNOS might be able to compensate for increased oxidative stress leading to preserved endothelial function at the start of diabetes followed by a final reduction in endothelium response as the disease progresses leading to endothelial dysfunction. In the light of these findings, we can conclude that despite marked hyperglycaemia and increased oxidative stress, endothelium-dependent and endotheliumindependent relaxations were maintained after 6 weeks of streptozotocin-induced diabetes due to increased nitric oxide bioavailability. The increase in nitric oxide bioavailability could be attributed to increased expression of eNOS and calmodulin and/or release from nitrosothiol stores. The nitric oxide could be acting through sGC as well as a sGC-independent pathway through activation of SK Ca and IK Ca channels to cause relaxation in diabetic rat aorta. Therefore, our results suggest that increased nitric oxide bioavailability is a compensatory mechanism to counteract increased oxidative stress in the early stages of diabetes to maintain endothelial function in aorta.
